PMID: 7370359Mar 1, 1980Paper

A conditioned response model of the placebo effect predictions from the model

Biofeedback and Self-regulation
I Wickramasekera

Abstract

A model of the placebo response as a conditioned response (CR) is presented and predictions from this model are listed. Through association with active ingredients (UCS), neutral (CS) places, persons, procedures, and things can come to acquire the ability to reduce pain, anxiety, and depressive responses. One major counterintuitive prediction from the model is that therapists who routinely use active ingredients (UCS) or powerful drugs will get stronger placebo effects than those who routinely use "inert" ingredients (CS) or weak drugs. Developmentally, placebo responding appears to involve two successive conditioning stages, which may involve first the left and later the right hemisphere in right-handed subjects. The relationship between placebo responding and hypnotizability is discussed.

References

Jul 1, 1976·The American Journal of Clinical Hypnosis·R Fabbri
Sep 23, 1978·Lancet·J D LevineH L Fields
Jul 1, 1978·Archives of General Psychiatry·K VerebeyD Clouet
Nov 1, 1978·Annals of Neurology·A I Basbaum, H L Fields
Oct 7, 1977·Annals of the New York Academy of Sciences·I E Wickramasekera
Oct 1, 1979·The American Journal of Clinical Hypnosis·K R Graham, K Pernicano
May 1, 1976·Psychological Bulletin·D L Schacter
Nov 1, 1977·Psychophysiology·H D CohenM R Cook
Oct 1, 1965·Journal of Consulting Psychology·E R HilgardJ M Cuca
Jan 1, 1974·The American Journal of Clinical Hypnosis·S Krippner, P R Bindler
Mar 1, 1973·Experimental Neurology·R Melzack, P R Bromage
Aug 1, 1973·Journal of Abnormal Psychology·I Wickramasekera
Jan 1, 1974·Psychological Review·M H Erdelyi
May 1, 1969·Psychosomatic Medicine·T H McGlashanM T Orne
May 1, 1967·Journal of the Experimental Analysis of Behavior·S R Goldberg, C R Schuster
Jan 1, 1969·Annual Review of Pharmacology·C R Schuster, T Thompson
Jul 1, 1970·Journal of the Experimental Analysis of Behavior·S R Goldberg, C R Schuster
Dec 1, 1971·Journal of Consulting and Clinical Psychology·S L GarfieldA E Bergin
Oct 1, 1969·The International Journal of Clinical and Experimental Hypnosis·I Wickramasekera
Jul 1, 1968·Behavioral Science·R K Schwitzgebel, M Traugott
Jun 1, 1969·Journal of Abnormal Psychology·R S Sanders, J Reyher
Jun 1, 1957·The American Journal of Psychiatry·L H GLIEDMANH A TEITELBAUM
Nov 9, 1962·Science·R J HERRNSTEIN
Jan 1, 1964·Scientific American·R W SPERRY
Jan 1, 1965·Annual Review of Psychology·E R HILGARD
Sep 1, 1951·Journal of Experimental Psychology·K W SPENCE, J TAYLOR

❮ Previous
Next ❯

Citations

Jun 1, 1997·Progress in Neurobiology·F Benedetti, M Amanzio
May 1, 1993·Psychological Medicine·R Ader
Jan 1, 1996·The International Journal of Clinical and Experimental Hypnosis·J Holroyd
Aug 19, 2011·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Justine E Owens, Martha Menard
May 25, 2010·Journal of Developmental and Behavioral Pediatrics : JDBP·Adrian D SandlerJames W Bodfish
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Luana Colloca, Franklin G Miller
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Luana Colloca, Franklin G Miller
Jan 1, 1996·International Journal of Behavioral Medicine·P J de JongH Merckelbach
Jan 19, 2007·International Journal of Behavioral Medicine·Rainer SchneiderHarald Walach
May 12, 2011·Journal of Pain Research·Andrea L Martin-PichoraJoel Katz
Jan 1, 2009·The International Journal of Biostatistics·Eva PetkovaUsha Govindarajulu
Feb 18, 2011·Psychonomic Bulletin & Review·Ben ColagiuriJustin A Harris
Jul 28, 2013·Social Cognitive and Affective Neuroscience·Marta PeciñaJon-Kar Zubieta
Apr 3, 2012·Neuroscience Letters·Lauren Y Atlas, Tor D Wager
Jan 31, 2012·Trends in Pharmacological Sciences·Bettina K Doering, Winfried Rief
Jul 20, 2010·Patient Education and Counseling·Jozien M Bensing, William Verheul
May 1, 2015·The American Journal of Clinical Hypnosis·Elisa FrisaldiFabrizio Benedetti
Jun 25, 2005·Mental Retardation and Developmental Disabilities Research Reviews·Adrian Sandler
Mar 17, 2004·Journal of Clinical Psychology·Irving KirschRalph R Miller
Apr 3, 2009·Annals of the New York Academy of Sciences·Jon-Kar Zubieta, Christian S Stohler
Feb 20, 2007·Pain Practice : the Official Journal of World Institute of Pain·Edvin B Koshi, Christine Ann Short
Jan 4, 2008·Child: Care, Health and Development·A D Sandler, J W Bodfish
Aug 28, 2014·European Journal of Pain : EJP·E CarlinoF Benedetti
Mar 13, 2014·Clinical and Experimental Pharmacology & Physiology·Victor C NwazueSatish R Raj
Sep 1, 1989·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·R Ader
Jan 1, 1985·Annals of the New York Academy of Sciences·R Ader
Oct 1, 1983·The Journal of Pediatrics·L H Epstein, P A Cluss
Oct 26, 2005·Brain, Behavior, and Immunity·Jon-Kar ZubietaChristian S Stohler
Aug 15, 2015·Neuroscience·B ColagiuriL Colloca
Nov 25, 2014·Eating and Weight Disorders : EWD·Nino Rekhviashvili, Sumati Gupta
Nov 21, 2014·Medicine and Science in Sports and Exercise·Ramzy RossJason M R Gill
Jun 20, 2015·Nature Reviews. Neuroscience·Tor D Wager, Lauren Y Atlas
Nov 21, 2015·Psychosomatic Medicine·Veronica Frances Quinn, Ben Colagiuri
Jan 1, 1985·International Journal of Psychiatry in Medicine·M P Jensen, P Karoly
Jul 16, 2014·Pain·Christopher T McNabbPerry N Fuchs
Oct 1, 1992·Pain·P D Wall
Aug 1, 1997·Pain·G H Montgomery, I Kirsch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.